Roswell Park Set to Open Several New Trials this Year for Innovative CAR T-Cell Therapies - Takeaways - MDSpire

Roswell Park Set to Open Several New Trials this Year for Innovative CAR T-Cell Therapies

CAR T-cell therapies are the future of cancer treatment and Roswell Park Comprehensive Cancer Center is preparing to open a number of new trials based on research originating here and in partnership with the industry.

  • March 17, 2025

Share

  • 1

    Roswell Park Comprehensive Cancer Center is launching several new CAR T-cell therapy trials in 2025, focusing on innovative cancer treatments.

  • 2

    A phase 1 trial will investigate a CAR T-cell therapy targeting CD19 for patients with relapsed B-cell malignancies.

  • 3

    New trials will also target solid tumors, including ovarian, bladder, and breast cancers, utilizing advanced CAR T-cell technologies.

  • 4

    Innovative CAR T-cell therapies include engineered T-cells designed to resist hostile tumor microenvironments for improved efficacy.

  • 5

    Roswell Park's trials are first-in-human studies, emphasizing the center's commitment to pioneering cancer treatment advancements.

Original Source(s)

Roswell Park Set to Open Several New Trials this Year for Innovative CAR T-Cell Therapies

  • March 17, 2025

Related Content

Management of toxicities from antibody – drug conjugates in breast cancer

Synthetic short RNA in cancer

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy